Peculiarities of arterial hypertension in patients with acromegaly in active phase


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Analysis of changes of indicators of daily monitoring of arterial pressure (DMAP) in 46 patients with acromegaly in the active phase is given. Systolic-diastolic arterial hypertension was registered in 2/3 of patients. In the analysis of their diurnal profile of blood pressure (BP) the insufficient reduction of BP during the night and cases of nocturnal hypertension were noticed. DMAP is advisable in all patients with acromegaly to register the presence of arterial hypertension, objectification of level of BP and its diurnal dynamics, selection and monitoring of antihypertensive therapy.

全文:

受限制的访问

作者简介

Yuliya Zaviyalova

Nizhny Novgorod State Medical Academy

Email: j.zavialova@mail.ru
PhD, Assistant Professor of the Department of hospital therapy

Nikolay Borovkov

Nizhny Novgorod State Medical Academy

Email: borovkov-nn@mail.ru
MD, professor, Head of Department of hospital therapy

Olga Zanozina

Nizhny Novgorod State Medical Academy

Email: zwx2@mail.ru
MD, Professor of the Department of hospital therapy

Nataliya Borovkova

Nizhny Novgorod State Medical Academy

Email: borovkov-nn@mail.ru
MD, Professor of the Department of hospital therapy

参考

  1. Аметов А.С., Доскина Е.В. Акромегалия и гигантизм. М.: ГЭОТАР-Медиа, 2010. [Ametov A.S., Doskina Ye.V. Acromegaly and gigantism. Moscow: GEOTAR-Media, 2010. (in Russian)]
  2. Дедов И.И., Молитвословова Н.Н., Марова Е.И. Акромегалия: патогенез, клиника, диагностика, дифференциальная диагностика, методы лечения. Пособие для врачей. Тверь: Триада, 2006. 48 с. [Dedov I.I., Molitvoslovova N.N., Marova Ye.I. Acromegaly: pathogenesis, clinical features, diagnosis, differential diagnosis, treatment. Manual for physicians. Tver: Triad, 2006. 48 p. (in Russian)]
  3. Пронин В.С., Чаплыгин Е.В., Потешкин Ю.Е. Особенности течения и лечения артериальной гипертензии у больных акромегалией. Фарматека. 2009;17:83-7. [Pronin V.S., Chaplygin Ye.V., Poteshkin Yu.Ye. Features of the course and treatment of hypertension in patients with acromegaly. Pharmateca. 2009;17:83-7 (in Russian)]
  4. Palmeiro C.R., Anand R., Dardi I.K., Balasubramaniyam N., Schwarcz M.D., Weiss I.A. Growth hormone and the cardiovascular system. Cardiol. Rev. 2012;20(4):197-207.
  5. Fedrizzi D., Czepielewski M.A. Cardiovascular disturbances in acromegaly. Arq. Bras. Endocrinol. Metabol. 2011;52(9):1416-29.
  6. Berg C., Petersenn S., Lahner H., Herrmann B.L., Buchfelder M., Droste M., Stalla G.K., Strasburger C.J., Roggenbuck U., Lehmann N., Moebus S., Jöckel K.H., Möhlenkamp S., Erbel R., Saller B., Mann K. Cardiovascular risk factors in patients with uncontrolled and longterm acromegaly: comparison with matched data from the general population and the effect of disease control. J. Clin. Endocrinol. Metab. 2013;95:3648-56.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2016
##common.cookie##